Document:

<PAGE>   1
                                  EXHIBIT 10.5

                        AMENDMENT TO EMPLOYMENT AGREEMENT

         THIS AMENDMENT TO EMPLOYMENT AGREEMENT dated as of the 31st day of
December, 1998 by and between GENELINK, INC., a Pennsylvania corporation (the
"Company"), and JOHN R. DEPHILLIPO ("Executive").

                                   BACKGROUND

         The Company and Executive are parties to an Employment Agreement dated
as of February 24, 1998 (the "Original Employment Agreement"), pursuant to which
Executive is employed as president and chief executive officer of the Company.

         The parties hereto desire to amend the Employment Agreement as further
set forth below.

         NOW, THEREFORE, in consideration of the foregoing and the mutual
covenants contained herein, the parties agree as follows:

         1. Amendment to Paragraph 3(d). Paragraph 3(d) of the Original
Employment Agreement is hereby amended to read in its entirety as follows:

         "(d) Repayment of Loans. Executive may pay any loans or advances made
         to him by the Company using cash, Company Shares, options to acquire
         Company Shares, or any combination, by December 31, 2003, unless
         extended by the Company."

         2. Full Force and Effect. Except as expressly amended hereby, the
Original Employment Agreement shall remain valid, binding and in full force and
effect.

                                       1
<PAGE>   2
         IN WITNESS WHEREOF, the parties have executed this Amendment as of the
date first above written.

                                        /s/ John DePhillipo
                                        --------------------------
                                            JOHN DEPHILLIPO

                                        GENELINK, INC.

                                        By: /s/ John R. DePhillipo
                                            ----------------------

                                       2<PAGE>   1
                                  EXHIBIT 10.6

                              CONSULTING AGREEMENT

         CONSULTING AGREEMENT ("Agreement") made and entered as of February 24,
1998 by and among GENELINK, INC. (the "Company"), a Pennsylvania corporation and
ROBERT P. RICCIARDI, PH.D. (the "Consultant").

                                   BACKGROUND

         The parties want to enter into a consulting agreement and to set forth
the terms and conditions of the Consultant's relationship with the Company.
Accordingly, in consideration of the mutual covenants and agreements set forth
herein and the mutual benefits to be derived herefrom, and intending to be
legally bound, the Company and the Consultant agree as follows:

         1.       ENGAGEMENT

                  (a) Duties. The Company will engage the Consultant, on the
terms set forth in this Agreement, as a consultant and Treasurer. The Consultant
accepts such relationship with the Company and will perform and fulfill such
duties as are reasonable and necessary for such position for the Company and its
subsidiaries, devoting his best efforts to the performance and fulfillment of
his duties and to the advancement of the interests of the Company, subject only
to the direction of the Board of Directors of the Company (the "Board"). In no
event will the Consultant be required to provide more than eight (8) hours of
consulting services in any week. Notwithstanding the foregoing, the Company will
not require Consultant to provide more hours of service per week than would be
allowed by his current (or any future) position with the University of
Pennsylvania or other academic institution.

                                       1
<PAGE>   2
                  (b) Place of Performance. In his engagement by the Company,
the Consultant will be based in the Philadelphia, Pennsylvania metropolitan
area, except for required travel on Company business.

         2.       TERM

         The Consultant's engagement under this Agreement will be for a five
year term (the "Term") commencing as of the date of an initial closing of the
Company' limited offering (the "Commencement Date") and will continue
uninterrupted for the Term. Each year, unless one party notified the other party
in writing by sixty (60) days prior to the anniversary of the Commencement Date
(the "Anniversary Date"), on the Anniversary Date, the parties will
automatically extend the Term for an additional year. The parties intend the
effect that a full five year Term will always exist under this Agreement.

         3.       COMPENSATION

                  (a) Base Compensation. During the Term, the Consultant will be
entitled to receive annual compensation in the calendar year 1998 of $30,000 and
in the calendar year of 1999 of $60,000 (the "Base Compensation"). Each year
thereafter, Consultant will be entitled to an increase in the Base Compensation
equal to the greatest of: (i) the percentage increase in the Consumer Price
Index for the previous year as reported by the United States Department of
Commerce; (ii) 10%; or (iii) an amount determined by the Board or a committee of
the Board designated for this purpose, payable in installments at such time as
the Company customarily pays its senior management (but in any event no less
often than monthly). The increase determined in the previous sentence will be
added to the then current Base Compensation to become the Base Compensation for
purposes of this Agreement.

                                       2
<PAGE>   3
                  (b) If there is a change in control such as would require the
Company to file a Form 8-K with the Securities and Exchange Commission if the
Company was a reporting company under the Securities Exchange Act of 1934 (a
"Change in Control"), the Consultant will be entitled to be paid a lump sum
payment equal to the aggregate Base Compensation, with minimum 10% increases
each year, for the next five years, and a lump sum bonus equal to five times the
largest bonus paid to Consultant under this Agreement. The Company will pay the
payments required under the previous sentence within 30 days of the Change in
Control.

                  (c) Bonus. Consultant will receive an annual bonus according
to a Company Bonus Plan adopted by the Board.

         4. INSURANCE AND OTHER BENEFITS

         During the Term, the Consultant will be entitled to opt into all
benefits offered by the Company to its key management employees, including,
without limitation, all pension, profit sharing, retirement, stock option,
deferred compensation, disability insurance, survivor benefits, life insurance
or any other benefit plan or arrangement established and maintained by the
Company, subject to the rules and regulations then in effect regarding
participation therein. In addition, the Company will obtain and fund for
Consultant a life insurance policy for $1,000,000, with beneficiary to be named
by Consultant.

         5.       REIMBURSEMENT OF EXPENSES

         The Company will reimburse Consultant for all items of travel,
entertainment and miscellaneous expenses that the Consultant reasonably incurs
in the performance of his duties hereunder, if the Consultant submits to the
Company evidence supporting these expenses as the Company may reasonably
require.

                                       3
<PAGE>   4
         6.       OPTIONS: GRANT OF SHARES

         Upon the execution of this Agreement, the Company will issue to
Consultant options to purchase 1,000,000 shares (the "Shares") of the Company's
common stock $.01 par value, exercisable at the price of $0.10 per Share. These
options will expire ten years from the date hereof and will vest as follows:

200,000 Shares upon execution of this Agreement, and

         200,000 Shares each January 1, beginning January 1, 1999. Options will
be exercisable upon vesting. If there is a Change of Control, all unvested
options will be immediately exercisable. The Consultant may exercise vested
options by giving the Company a note equal to the exercise price of the options
exercised, which will bear interest at a floating rate equal to the Federal
Funds Rate published in the Wall Street Journal as adjusted from time to time.
In the alternative, the Consultant may use Shares owned by the Consultant may
retire debt of the Company to the Consultant in return for Shares. Shares issued
or to be issued pursuant to these options will be registered for re-sale by the
Company on a Form S-8 as soon as the Company is eligible to use Form S-8. The
Company will bear the entire cost of such registration.

                                       4
<PAGE>   5
         The Consultant will also be eligible to participate in any stock
option, stock grant, phantom stock, or other incentive plan when, as and if
approved by the Board. Eligibility in no way creates an obligation of the
Company to issue options to the Consultant, which will be in the sole and
absolute discretion of the Compensation Committee of the Board.

         The stock grants and options granted under this Section 6 of the
Agreement will be adjusted for any recapitalizations, stock dividends, stock
splits or other changes in the Company's capital stock.

         7.       TERMINATION OF EMPLOYMENT

         Death and Total Disability. If the Consultant dies during the Term,
this Agreement will end as of the date of the Consultant's death. The Company
will pay the Consultant's compensation for the remaining Term to Consultant's
beneficiary or estate. In case of Total Disability (as defined below) of the
Consultant for any consecutive twelve months during the Term, the Company will
have the right to end this Agreement by giving the Consultant thirty (30) days'
prior written notice, and upon the expiration of such thirty (30) day period,
the Consultant's employment under this Agreement will end. If there is such a
termination, the Company will pay Consultant his Compensation for the remaining
Term. If the Consultant will resume his duties within thirty (30) days after
receipt of such a notice of termination, this Agreement will continue in full
force and effect. Upon termination of this Agreement under this Section 9(a),
the Company will have no further obligations or liabilities

                                       5
<PAGE>   6
under this Agreement, except to pay to the Consultant's estate or the
Consultant, as the case may be, the portion of Compensation that remains unpaid
for the Term, including minimum increases and continuation of benefits. The term
"Total Disability", as used herein, will man a mental or physical condition that
in the reasonable opinion of an independent medical doctor selected by the
Company renders the Consultant unable or incompetent to carry out the material
duties and responsibilities of the Consultant under this Agreement at the time
the Consultant incurred the disabling condition. If the Consultant is covered
under any policy of disability insurance under Section 4, the definition of
Total Disability hereunder will be the definition of that term in such policy.

         The Company may only terminate this Agreement for cause under this
Section 9(b) or under Section 9(a) of this Agreement. Cause for termination
exists only if the Consultant is convicted of a felony involving fraud or
violation of the Federal Securities laws, or a court of competent jurisdiction
finds that the Consultant has engaged in conduct involving the Company that
constitutes gross negligence or intentional misconduct. If the Company
terminates the Consultant under this section, all unvested options or stock
grants will be void and the Consultant will not receive any Compensation or
benefit continuation.

         8. NO MITIGATION

         This Agreement does not require the Consultant to mitigate the amount
of any payment or benefit provided for in this Agreement by seeking other
employment or otherwise, nor will the

                                       6
<PAGE>   7
amount of any payment provided for in this Agreement be reduced by any
compensation earned by the Consultant as the result of his employment by another
employer.

         9. RESTRICTIVE COVENANT

         Competition. Consultant undertakes and agrees that until two years
after termination of this Agreement, he will not compete, directly or
indirectly, or participate as a director, officer, employee, consultant agent,
consultant, representative or otherwise, or as a stockholder, partner or joint
venturer, or have any direct or indirect financial interest, including, without
limitation, the interest of a creditor, in any business competing directly or
indirectly with the business of Company or any of its subsidiaries.

         Trade Secrets. During the Term and after termination for any reason,
Consultant will not reveal, divulge, copy or otherwise use any trade secret of
the Company or its subsidiaries, it being acknowledged that all such information
and materials compiled or obtained by or disclosed to Consultant while employed
by the Company or its subsidiaries hereunder or otherwise are confidential and
are the exclusive property of the Company and its subsidiaries.

         Injunctive Relief. The parties hereto agree that the remedy at law for
any breach of the provisions of this Section 9 will be inadequate and that this
Agreement entitles the Company or any of its subsidiaries or other successors or
assigns to injunctive relief without a bond. Such injunctive relief will not be
exclusive, but will be in addition to any other rights and remedies Company or
any of its subsidiaries or their successors or assigns might have for such
breach.

                                       7
<PAGE>   8
         Scope of Covenant. Should the duration, geographical area or range or
proscribed activities contained in subparagraph (a) be held unreasonable by any
court of competent jurisdiction, then such court may modify the duration,
geographical area or range of proscribed activities to such degree as to make it
or them reasonable and enforceable.

         10. INDEMNITY

         The Company will indemnify and hold the Consultant harmless to the
maximum extent permitted by law against any claim, action, demand, loss, damage,
cost, expense, liability or penalty arising out of any act, failure to act,
omission or decision by him while performing services as an officer, director or
employee of the Company, other than an act, omission or decision by the
Consultant that is not in good faith and is without his reasonable belief that
the same is, or was, in the best interests of the Company. To the extent
permitted by law, the Company will pay all attorneys' fees, expenses and costs
actually incurred by the Consultant in the defense of any of the claims
referenced herein.

         11. MISCELLANEOUS

         Notices. Any notice, demand or communication required or permitted
under this Agreement will be in writing and will either be hand-delivered to the
other party or mailed to the addresses set forth below by registered or
certified mail, return receipt requested or sent by overnight express mail or
courier or facsimile to such address, if a party has a facsimile machine. Notice
will be deemed to have been given and received when so hand-delivered or after
three business days when so deposited in the U.S. Mail, or when transmitted and

                                       8
<PAGE>   9
received by facsimile or sent by express mail properly addressed to the other
party. The addresses are:

                           To the Company:        GeneLink, Inc.
                                                  P.O. Box 3212
                                                  Margate, NJ 08402
                                                  Fax No. (609) ____-________

                           To the Consultant:

The parties may change the foregoing addresses at any time by written notice
given in the manner herein provided.

         Integration; Modification. This Agreement is the entire understanding
and agreement between the Company and the Consultant regarding its subject
matter and supersedes all prior negotiations and agreement, whether oral or
written, between them with respect to its subject matter. This Agreement may not
be modified except by a written agreement signed by the Consultant and a duly
authorized officer of the Company.

         Enforceability. If any provision of this Agreement will be invalid or
unenforceable, in whole or in part, such provision will be deemed to be modified
or restricted to the extent and in the manner necessary to render the same valid
and enforceable, or will be deemed excised from this Agreement, as the case may
be, and this Agreement will be construed and enforced to the maximum extent
permitted by law as if such provision had been originally incorporated herein as
so

                                       9
<PAGE>   10
modified or restricted, or as if such provision had not been originally
incorporated herein, as the case may be.

         Binding Effect. This Agreement will be binding upon and inure to the
benefit of the parties, including and their respective heirs, executors,
successors and assigns, except that the Consultant may not assign this
Agreement.

         Waiver of Breach. No waiver by either party of any condition or of the
breach by the other of any term or covenant continued in this Agreement, whether
by conduct or otherwise, in any one or more instances will be deemed or
construed as a further or continuing waiver of any such condition or breach or a
waiver of any other condition, or the breach of any other term or covenant set
forth in this Agreement. Moreover, the failure of either party to exercise any
right hereunder will not bar the later exercise of it.

         Governing Law and Interpretation. The internal laws of the Sate of New
Jersey will govern this Agreement. Each party agrees that he or it, as the case
may be, will deal fairly and in good faith with the other party in performing,
observing and complying with the covenants, promises, duties, obligations, terms
and conditions to be performed, observed or complied with by him or it, as the
case may be, hereunder; and that this Agreement shall be interpreted, construed
and enforced according to this covenant despite any law to the contrary.

                                       10
<PAGE>   11
         Headings. The headings of the various sections and paragraphs have been
included herein for convenience only and will not be considered in interpreting
this Agreement.

         Counterparts. The parties may execute this Agreement in several
counterparts, each of which will be deemed to be an original but al of which
together will make up the same instrument.

IN WITNESS WHEREOF, the Consultant and the duly authorized officers of the
Company have executed this Agreement on the date first written above.

                                            GENELINK, INC.

                                            By:   /s/ John R. DePhillipo
                                                      John R. DePhillipo

                                                   /s/ Robert P. Ricciardi
                                                       Dr. Robert P. Ricciardi

                                       11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}]]